Key result
Radical surgery for primary retroperitoneal sarcomas yields ~48% five-year survival.
Why the study?
The impact of aggressive surgical treatment on long-term survival in patients with primary retroperitoneal sarcomas was evaluated due to limited outcome data.
Does aggressive surgical treatment improve survival in patients with primary retroperitoneal soft tissue sarcomas?
Population
42 patients with primary retroperitoneal sarcomas undergoing surgical exploration from 1984 to 1995
Comparison
Radical surgery vs non-radical surgery
Design
Retrospective cohort study
Follow-up
5 years
Authors
Loading...
Supports radical resection for potential long-term survival in retroperitoneal sarcomas; leaves open comparative effectiveness and adjuvant strategies.
Cohort (n=42)
No
Does aggressive surgical treatment improve survival in patients with primary retroperitoneal soft tissue sarcomas?
Wide surgical excision offers a concrete chance for long-term survival in patients with primary retroperitoneal sarcomas, though tumor classification and stage remain significant prognostic factors.
Malerba et al. (1999) conducted a cohort in Primary retroperitoneal sarcomas (n=42). Radical surgery was evaluated on 5-year survival. Radical surgery for primary retroperitoneal sarcomas resulted in a 5-year survival of 48.1% and a 5-year disease-free survival of 38.8%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: